Philidor specialty pharmacy controversy

E1979948 UNEXPLORED

The Philidor specialty pharmacy controversy was a major scandal involving Valeant Pharmaceuticals’ use of a closely linked mail-order pharmacy to inflate drug sales and manipulate distribution practices, triggering regulatory scrutiny and public outrage over drug pricing.

Try in SPARQL Jump to: Surface forms Referenced by

All labels observed (1)

Label Occurrences
Philidor specialty pharmacy controversy canonical 1

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.

Valeant Pharmaceuticals involvedIn Philidor specialty pharmacy controversy